Hangzhou Tigermed Consulting Co., Ltd. — 2026 EGM Poll Results and Special Resolution Passed
Hangzhou Tigermed Consulting Co., Ltd. Announces Results of 2026 First Extraordinary General Meeting
Date: March 5, 2026
Location: Meeting Room, 18/F, Shengda Science Park Tower A, No. 19 Jugong Road, Binjiang District, Hangzhou, PRC
Key Highlights for Investors
- Special Resolution Passed: Shareholders overwhelmingly approved the special resolution relating to the change of the Company’s registered address and amendments to the Articles of Association.
- Strong Shareholder Participation: Approximately 50.43% of total issued shares with voting rights participated in the EGM, representing a robust turnout.
- Legal Confirmation: The meeting and voting procedures conformed to all relevant PRC laws, regulations, and the Company’s Articles, confirming the legality and validity of the EGM.
- Unanimous H Shareholder Support: 100% of voting H Shares supported the resolution, with no votes against or abstentions.
- Price-Sensitive Event: The change of registered address and corresponding amendments to the Articles of Association may impact the Company’s operational flexibility and regulatory status, which could be regarded as price sensitive.
Detailed Report and Shareholder Information
Meeting Overview
The Board of Directors of Hangzhou Tigermed Consulting Co., Ltd. convened its 2026 First Extraordinary General Meeting (EGM) on March 5, 2026. The meeting was chaired by Dr. Ye Xiaoping, the Chairman of the Board. All seven Directors attended the meeting, either in person or via video conference, signifying the importance of the matters discussed.
Voting and Scrutiny
The EGM was conducted via poll, in accordance with the Listing Rules and the Company’s Articles of Association. Legal advisors from Jia Yuan Law Offices and representatives from Tricor Investor Services Limited, the H Share registrar, acted as scrutineers to ensure fair and accurate counting of votes.
Legal counsel confirmed the legitimacy of the meeting, including the qualification of attendees and the voting process, ensuring full compliance with PRC Company Law, Securities Law, and other relevant regulations.
Share Capital and Voting Rights
- Total Issued Shares: 861,026,050
- Treasury Shares (non-voting): 5,883,780 A Shares
- Total Shares with Voting Rights: 855,142,270 (including 732,017,470 A Shares and 123,124,800 H Shares)
- Shares Voted at EGM: 431,255,969 (approx. 50.43% participation)
Of these, 383,343,653 were A Shares (44.83% of total voting shares) and 47,912,316 were H Shares (5.60% of total voting shares).
Resolution Details and Voting Results
Resolution: To approve the change of the Company’s registered address and corresponding amendments to the Articles of Association.
| Share Class |
For |
Against |
Abstain |
| A Shares |
383,192,121 (99.9605%) |
79,100 (0.0206%) |
72,432 (0.0189%) |
| H Shares |
47,912,316 (100%) |
0 (0%) |
0 (0%) |
| Total |
431,104,437 (99.9649%) |
79,100 (0.0183%) |
72,432 (0.0168%) |
The overwhelming support (over two-thirds required, nearly unanimous approval) means the resolution was duly passed.
Additional Shareholder Information
- No shareholder was required to abstain from voting according to the Listing Rules.
- No votes were cast against or abstained in a manner that would affect the passage of the resolution.
- No shareholders had indicated in advance any intention to oppose or abstain from the resolution.
Potential Impact on Share Value
The approved changes to the registered address and the Articles of Association reflect a significant corporate action. Such moves may signal operational repositioning or regulatory optimization, both of which could impact future business strategy, transparency, or governance. Investors should monitor subsequent disclosures for further developments, as these changes can influence market confidence and, potentially, the share price.
Board Composition (for Reference)
- Executive Directors: Dr. Ye Xiaoping, Ms. Cao Xiaochun, Mr. Wu Hao, Mr. Wen Zengyu
- Independent Non-Executive Directors: Mr. Liu Kai Yu Kenneth, Mr. Yuan Huagang, Ms. Liu Yuwen
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are advised to review the official documents and consult with financial professionals before making investment decisions. The passage of special resolutions and amendments to corporate documents can have significant effects on a company’s operations and share value. Please exercise caution and stay informed of future announcements by Hangzhou Tigermed Consulting Co., Ltd.
View TIGERMED Historical chart here
